Patent directory · USPTO A61K / A61P
Patents matching “ONCOLYTICS BIOTECH INC.”
63 pharma patents match "ONCOLYTICS BIOTECH INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 63 pharmaceutical patents matching "ONCOLYTICS BIOTECH INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7014847
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
expired -
US 6994858
Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
expired -
US 6811775
Reovirus for the treatment of cellular proliferative disorders
expired -
US 6808916
Method of extracting virus from cell culture
expired -
US 6703232
Method of producing infectious reovirus
expired -
US 6649157
Viruses for the treatment of cellular proliferative disorders
expired -
US 6596268
Viruses for the treatment of cellular proliferative disorders
expired -
US 6576234
Reovirus for the treatment of neoplasia
expired -
US 6565831
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
expired -
US 6528305
Method of producing infectious reovirus
expired -
US 6455038
Reovirus for the treatment of cellular proliferative disorders
expired -
US 6344195
Reovirus for the treatment of neoplasia
expired -
US 6261555
Reovirus for the treatment of neoplasia
expired -
US 6136307
Reovirus for the treatment of cellular proliferative disorders
expired -
US 6110461
Reovirus for the treatment of neoplasia
expired